Replies to post #195300 on Enzolytics Inc (ENZC)

[docsetc]

Yeah Doink, if Charles does not have other funding sources from private test results soon, the competition will complete their fly-by and make the company irrelevant.

-- Did they ever really intend any African Trials?
-- Did they ever get any results from said volunteer trials?
-- Is Chandra even still legally with ENZC other than being a preferred shareholder?
-- Is the lab at A&M even still open at the PreClinical Trial center? We'll know on 4/24/2024.
-- Are there any proven results even in a 1-person test result for Clone3 or Clone7 ??
-- Are half of the listed Board Members doing anything with ENZC now?

Some of the above may sound silly, until you begin to think about it and review all DD.
If I see a patent approval spike by late Summer or earlier, I'm probably selling it all.
As always, I'd be happy to be wrong, but I've seen a lot of these. ENZC had more ground underneath them than most OTC Biopharma's, but it's all crumbling now.

GLTA

[docsetc]

Yeah Doink, if Charles does not have other funding sources from private test results soon, the competition will complete their fly-by and make the company irrelevant.

-- Did they ever really intend any African Trials?
-- Did they ever get any results from said volunteer trials?
-- Is Chandra even still legally with ENZC other than being a preferred shareholder?
-- Is the lab at A&M even still open at the PreClinical Trial center? We'll know on 4/24/2024.
-- Are there any proven results even in a 1-person test result for Clone3 or Clone7 ??
-- Are half of the listed Board Members doing anything with ENZC now?

Some of the above may sound silly, until you begin to think about it and review all DD.
If I see a patent approval spike by late Summer or earlier, I'm probably selling it all.
As always, I'd be happy to be wrong, but I've seen a lot of these. ENZC had more ground underneath them than most OTC Biopharma's, but it's all crumbling now.

GLTA